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Abstract
Context: The aqueous extracts of Cetraria islandica (L.) Ach. (Parmeliaceae) is traditionally used
in many countries against a number of conditions, including inflammatory conditions.
Objective: The present study aimed to assess, for the first time, the effectiveness of C. islandica in
cultured primary blood cells of Type 1 diabetes subjects.
Materials and methods: Diabetic and control blood samples were treated with or without
aqueous lichen extract (5 and 10mg mL1) for 48 h. The activity of antioxidant enzymes in
erythrocytes and also malondialdehyde levels in plasma were determined to evaluate the
oxidative status. DNA damages were analyzed by SCE, MN and comet assays in cultured human
lymphocytes. Additionally, proliferation index (PI) was evaluated in peripheral blood
lymphocytes.
Results: There were significant increases in observed total DNA damage (comet assay) (240.2%)
and SCE (168.8%), but not in MN frequencies of cultures with diabetes as compared (p40.05) to
controls. Whereas, the significant reductions of total DNA damage (69.2 and 65.3%) and SCE
frequencies (17.7 and 12.3%) were determined when the 5 and 10 mg mL1 lichen extract was
added to the cell culture medium, respectively. However, lichen extract did not completely
inhibit the induction of SCEs in lymphocytes of patients with diabetes. C. islandica extract was
also useful on PI rates.
Discussion: In conclusion, the antioxidant role of C. islandica in alleviating diabetes-induced
genomic instability and for increasing cell viability was firstly indicated in the present study.
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Introduction
Lichens are ecologically obligate symbiotic associations
between a fungus (mycobiont) and at least one photosynthetic
organism (photobionts; an alga, a cyanobacterium or both)
(Widmer et al., 2012). We documented that they are effective
in the treatment of tuberculosis (Vartia, 1973), hemorrhoids
and dysentery (Dülger et al., 1998) and induce apoptosis in
colon (Bezivin et al., 2003; Ren et al., 2009) and prostate
cancers (Mitrović et al., 2011; Russo et al., 2006). The lichens
also have antioxidant, antimicrobial and anticancer properties
(Cansaran, 2010; Cansaran et al., 2007; Halici et al. 2005;
Odabasoglu et al., 2006; Kosanic & Rankovic, 2011; Zambare
& Christopher, 2012). Unique lichen flora has attracted many
researchers on a systematic basis (Aslan et al., 2002). It is
pointed out that lichens may be easily accessible sources of
natural drugs that could be used as a possible food supplement
or in the pharmaceutical industry (Archer et al., 2008).
Type 1 diabetes (T1D) is a chronic condition with a rising
incidence worldwide in developed as well as in developing
countries (Malerbi et al., 2012). Because of the early age of
onset and longer diabetes duration, children and adolescents
are at risk for developing diabetes-related complications at a
younger age. As these youth age, this profoundly affects their
productivity, quality of life, and life expectancy and increases
health care costs (Imperatore et al., 2012). Over the past two
decades our increased understanding of the pathogenesis of
this disease has led to the development of new treatments.
Oxidative stress has been implicated in the T1D pathogenesis
(Bhatti et al., 2011; Lao-ong et al., 2012). In recent years,
there has been a growing interest in the antioxidant defense
system as a regulator of disease development. This opens up
an important strategy for therapy of diabetes and may provide
a promising avenue for future approaches to lichens. In
response to pharmacological activation or oxidative stress, we
studied well-known lichen species Cetraria islandica Ach.
(1830) (Parmeliaceae) in relation to the survival of the blood
cells in subjects with T1D. In many countries, C. islandica is
used medicinally, e.g., for colds, bronchitis, and asthma
(Safonova et al., 1999; Senchilo & Senchilo, 2004) and is
studied for antioxidant properties with in vitro conditions
(Kotan et al., 2011; Odabasoglu et al., 2006). The medicine is
usually taken in the form of a tea (decoction or infusion) of
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the dry lichen. C. islandica extract demonstrates hepatopro-
tective and also immune-stimulating effects in blood tissue
(Cernescu et al., 2011a; Freysdottir et al., 2008). Our study
investigated the efficacy of C. islandica against diabetes-
induced DNA damage with in vitro conditions. Firstly, some
oxidative parameters including superoxide dismutase (SOD),
catalase (CAT), glutathione peroxidase (GSH-Px) and mal-
ondialdehyde (MDA) which are used to monitor the devel-
opment and extent of damage due to oxidative stress in human
blood were investigated. Secondly, genotoxicity using single
cell gel electrophoresis (SCGE or comet), sister-chromatid
exchange (SCE), micronucleus (MN) assays, which are rapid
and sensitive methods for measuring the genetic damage,
were evaluated. In addition, the proliferation index (PI) rate
was assessed to provide information on cell viability.
Ultimately, the data may be used to devise strategies to
reduce the risk of T1D in humans. To our knowledge, these
results provide for the first time cellular information of C.
islandica on blood of humans with T1D.
Materials and methods
Lichen extract and dose adjustment
C. islandica was collected from the Giresun, Erzurum and
Artvin province in Turkey, during summer of 2009. The
samples were identified using various flora books and papers
(Aslan, 2000; Aslan et al., 2002). The identified sample was
air-dried and stored in the herbarium of Kaz|m Karabekir
Education Faculty. For water extraction of lichen, 20 g sample
was mixed with 400 mL distillated and boiling water using
magnetic stirrer for 15 min. Then the extract was filtered over
Whatmann No. 1 paper.
Experimental design and protocol
The study described effects of C. islandica in blood cultures of
patients with T1D. Thus, this study is divided into two sections.
Section 1: The assessment of antioxidant role of C. islandica
on T1D-induced oxidative stress and Section 2: Study of
effectiveness of C. islandica on T1D-induced DNA damage.
Blood samples were obtained by vein puncture from 25
children (age 10–18 years) diagnosed with T1D (disease
duration518 months) and also age and sex matched control
subjects. Human peripheral blood lymphocyte cultures were
set up according to a slight modification of the protocol
described by Evans and O’Riordan (1975). The heparinized
blood (0.5 mL) was cultured in 5 mL of culture medium
(Chromosome Medium B, Biochroms, Berlin) with
5 mg mL1 of phytohemagglutinin (Biochrome, Berlin,
Germany). C. islandica extract (5 and 10 mg mL1) was
added to the cultures just before incubation for biochemical
and cytogenetic analysis. The experiments were performed on
different groups as follows: T1D alone, C. islandica alone and
T1D plus C. islandica. The dosages of the lichen extract were
determined by preliminary dose-response work in our
laboratory and also the literature data (Kotan et al., 2011).
The study was performed in accordance with the Declaration
of Helsinki and with the approval of the local ethics
committee. In the patients with T1D, after supplementation
of C. islandica, the blood was incubated for 2 h at 37 C to
adjust body conditions, except for testing comet, SCE, MN
and PI (see below). Each individual whole blood culture
without disease or lichen extract was studied as a control
group (n¼ 8).
Erythrocytes
Erythrocytes were obtained from heparinized blood samples
by centrifugation (2500 g, for 20 min) at 4 C. The red cells
were then washed three times with 5 volumes of phosphate
buffered saline (PBS; 150 mmol L1 NaCl, 1.9 mmol L1
NaH2PO4, 8.1 mmol L
1 Na2HPO4, pH 7.4), and with a ratio




SOD activity was determined by the method of Misra and
Fridovich (1972), which is based on the ability of superoxide
dismutase to inhibit the process of epinephrine self-oxidation
in alkaline medium. In the reaction of colored adrenochrome
formation, the superoxide anion-radical is formed as an
intermediate product. Erythrocyte SOD activity was measured
by monitoring the increase in the absorbance at 480 nm.
CAT activity
CAT was determined in erythrocytes by the method of Aebi
(1984). To 3 mL H2O2 (54 mM H2O2 in 50 mM phosphate
buffer, pH 7.0), 5 mL of a catalase solution was added and
the decrease in H2O2 was measured spectrophotometrically
(Beckman DU 500, USA) at 240 nm for 60 s at 25 C. In the
erythrocyte preparations, hemolysates were centrifuged
(9000 g) and estimation of activity was made with 1%
hemolysates. One unit of catalase activity was defined as the
activity required for degrade 1 mmol hydrogen peroxide in 60 s.
GSH-Px activity
GSH-Px activity of erythrocytes was measured using hydro-
gen peroxide as substrate (Carlberg & Mannervik, 1972).
Potassium azide was added to inhibit catalase. Potassium
ferricyanide was added to inhibit the pseudo-peroxidase
activity of hemoglobin. Conversion of NADPH was moni-
tored continuously in a spectrophotometer at 340 nm for 3 min
at 25 C.
MDA level
The content of MDA was measured in plasma preparations by
the thiobarbutiric acid (TBA) method which was modified
from methods of Satoh (1978) and Yagi (1984). Peroxidation
was determined as the production of MDA that, in combin-
ation with TBA, forms a pink chromogen compound whose
absorbance at 532 nm was measured.
Cytogenetic analysis
SCE assay and proliferation index
With the aim of providing a better visualization of SCEs,
5-bromo-2-deoxyuridine (Sigma, St. Louis, MO, final
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concentration 20 mM) was added after culture initiation. The
cultures were incubated in complete darkness for 72 h at 37 C.
Exactly 70 h and 30 min after beginning of the incubations,
colcemid (Sigma) was added to the cultures to achieve a final
concentration of 0.5 mg L1. After hypotonic treatment
(0.075 M KCl) followed by three repetitive cycles of fixation
in methanol/acetic acid solution (3.1, v/v), centrifugation and
resuspension. The cell suspension was dropped on to chilled
and grease-free microscopic slides, air-dried, aged and then
differentially stained for inspection of the SCE rate according
to the fluorescence plus Giemsa (FPG) procedure (Perry &
Wolff, 1974). For each treatment condition, 25 well-spread
second division metaphases were scored and the values
obtained were calculated as SCEs per cell.
In addition to SCEs, cells were analyzed for the relative
frequency of first-division metaphases (M1; identifiable by
uniform staining of both sister chromatids), second-division
metaphases (M2; identifiable by differential staining of the
sister chromatids), and third- and subsequent division meta-
phases (M3; identifiable by nonuniform pattern of staining).
PI is the average number of replications completed by
metaphase cells and is calculated as follows:
PI ¼ 1 % M1ð Þ þ 2 % M2ð Þ þ 3 % M3ð Þ=100:
MN assay
The MN test was performed by adding cytochalasin B
(Sigma; final concentration of 6 mg mL1) after 44 h of
culture. At the end of the 72 h incubation period, the
lymphocytes were fixed with ice-cold methanol acetic acid
(1:1). The fixed cells were put directly on slides using a
cytospin, and stained with May Grünwald-Giemsa. All slides
were coded before scoring. The criteria for scoring micro-
nuclei were as described by Fenech (1993). At least 2000
binucleated lymphocytes were examined per concentration
(two cultures per concentration) for the presence of one, two
or more micronuclei.
Comet assay
The comet assay also known as single cell gel electrophoresis
(SCGE) was performed and scored according to Singh et al.
(1988), Banu et al. (2001) and Prabhavathy Das et al. (2006).
The cultures were set up by incubating lymphocytes for 72 h
with C. islandica in diabetic groups. The control cultures
were set up by incubating lymphocytes with the phosphate
buffered saline (PBS) (at a final concentration of 1%). Ten
milliliters of the 100 mL aliquots of the lymphocytes treated
as above along with untreated samples were mixed with
120 mL of 0.5% low melting agarose and layered on the
surface on glass slides previously coated with 140 mL of 1%
normal melting agarose. After the application of cover slips,
the slides were allowed to gel at 4 C for 20 min. After
carefully removing the cover slips, a second layer of 0.5%
low-melting agarose was pipetted on to the slides and allowed
to gel for a further 20 min at 4 C. The slides were immersed
in freshly prepared coldly lysing solution and refrigerated
overnight followed by alkali treatment, electrophoresis and
neutralization. The dried slides were then stained using silver
nitrate solution after appropriate fixing. The whole procedure
was carried out in dim light to minimize artifactual. DNA
damage analysis was performed at a magnification of 100
using a light microscope after coding the slides. A total of 100
cells were screened per slide. A total damage score for each
slide was derived by multiplying the number of cells assigned
to each grade of damage by the numeric value of the grade
and summing over all grades (giving a maximum possible
score of 400, corresponding to 100 cells at grade 4).
Statistics
The statistical analysis of experimental values was performed
by one-way analysis of variance (ANOVA) and Duncan’s test
using the SPSS 13.0 software the level of 0.05 was regarded
as indicative of statistical significance for all tests
Results
The effects of C. islandica on biochemical parameters in
blood cultures of diabetic patients are present in Table 1.
As compared with the controls, the activity of SOD, CAT and
also GSH-Px enzymes were markedly decreased in erythro-
cytes of patients with T1D while MDA increased (p50.05).
In the alone group, the C. islandica extract significantly
increased the level of antioxidant enzymes at both dosage
(5 and 10 mg mL1) but the effect of extract on the parameters
was not dose related. As presented in Table 1, lichen extracts
did not affect the MDA level measured in the human blood
plasma. Noteworthy, C. islandica brought the antioxidant
activity of erythrocytes closer to the control levels in blood
cultures with T1D. The increase of antioxidant capacity was
significant statistically in diabetic groups (p50.05) and MDA
level returned to the control levels. However, the effect of
extract on the MDA was not dose related (data not shown)
(Table 1).
The frequency of MN, SCEs, PI and the rate of primary
DNA damage (SCGE) in human lymphocytes were given in
Figures 1–4, respectively. In T1DþC. islandica groups,
separately and together, it was determined that the values of
MN were near to control groups (p40.05) (Figure 1).
Diabetes caused to generate a significant SCE rate in human
lymphocytes as compared with controls (p50.05). We also
compared SCE frequency in controls with and without
C. islandica and did not find any significant difference in
the frequency of SCE. On the contrary, C. islandica at both
doses reduced the SCE frequency, but the reduction of the
SCEs by lichen extract was sought in the blood with T1D
(p40.05) (Figure 2). Regarding PI values, our results showed
that treatments with C. islandica alone did not alter PI values
compared to the control. Whereas, a statistically important
decrease in the rate of PI was observed in patients with DM.
However, the treatments with C. islandica (at both concen-
trations) increased the rate of PI as compared to the group
with T1D alone (Figure 3). In the present study, comet assay
as DNA damage analysis was performed and quantified with
regard to diabetes and C. islandica administration (Figure 4).
It was shown that the level of primary DNA damage
significantly increased with T1D (p40.05), whereas there
were no differences between controls and C. islandica groups.
At the concentrations of C. islandica, it was clearly being
seen that the rate of DNA damage was significantly decreased
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against T1D (p50.05). Thus, C. islandica was established to
display beneficial effects on DNA, by returning these values
close to those of the control group after T1D disease.
However, the lichen extract did not show any evidence of
dose-related effect (data not shown).
Discussion
This study provides the first evidence that C. islandica has a
protective role against T1D-induced oxidative stress and
genomic instability in human blood. For T1D is an important
observation that this disease increases oxidative stress in
tissues (Perez-Gutierrez & Damian-Guzman, 2012; Tan et al.,
2007). Our results are in agreement with previous studies in
which T1D increases plasma level of MDA, an important
biological marker of lipid peroxidation (Bulum & Duvnjak,
2011; Yousefi et al., 2011). And it is suggested that the
positive relationship between MDA and T1D is significant
because disease leads to increased production of ROS and it
may also involve lipid peroxidation (Országhová et al., 2009).
Under these conditions, diabetes may induce vascular
dysfunction and hypertension (Naka et al., 2012). On the
other hand, lichens has been used for centuries in traditional
medicine and, especially over the last decade, many works
dealing with lichens have been published, but it still is a
matter of investigation by researchers of different properties
(Valente et al., 2011). Those are the reasons why we decided
to investigate the role of C. islandica in both the effects on
oxidative stress of T1D and its effect on DNA damages in
blood cells. The human body possesses a range of antioxidant
components, which are distributed among biological
fluids, tissues and cell compartments (Simões-Ambrosio
Table 1. The effects of C. islandica extract on biochemical parameters in healthy or diabetic human blood cultures.
Groups# SOD (U mL1) CAT (U g Hb1) GSH-Px (U mL1) MDA (mmol L1)
Control (C) 101.8 6.90b 234.2 7.68b 90.8 8.27b 355.4 12.99a
Diabetes(T1D) 51.6 4.97c 137.6 5.58c 52.4 6.34c 825.4 17.07b
C. islandica 5 mg mL1 117.1 7.36a 248.4 6.8a 107.9 7.62a 362.7 10.54a
T1DþC. islandica 5 mg mL1 92.7 5.26b 219.4 8.22b 82.40 4.87b 374.6 11.56a
Different letters within each column present a statistical difference by Duncan multiple range test at p50.05. Unit definition for SOD (U mL1): one
unit inhibits by 50% the maximum reduction of nitro blue tetrazoliumat 25 C, pH 7.0; for CAT (U g Hb1): one unit decomposes one micromole of
hydrogen peroxide per minute at 25 C, pH 7.0; for GSH-Px (U mL1): one unit catalyzes the oxidation by H2O2 of 1.0 mmol of reduced glutathione to
oxidized glutathione per min at pH 7.0 at 25 C; MDA (mmol L1).
#Values are presented as mean S.D.; n¼ 8.
Figure 1. The frequencies of MN in cultured human lymphocytes from
diabetic patients and control groups. Values are means standard
deviation; n¼ 8. Different letters within each bar present a statistical
difference by Duncan multiple range tests at p50.05.
Figure 2. The frequencies of SCEs in cultured human lymphocytes from
diabetic patients and control groups. Abbreviations are as defined in
Figure 1.
Figure 4. The effects of C. islandica extract on diabetic patients DNA
damage determinated by SCGE assay in lymphocytes. Abbreviations are
as defined in Figure 1.
Figure 3. The rates of PI after treatment with C. islandica extract on
human lymphocytes. Abbreviations are as defined in Figure 1.
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et al., 2010). Both enzymatic and non-enzymatic antioxidants
play an important role in inhibiting and scavenging free
radicals, thus providing protection to humans against infectious
and degenerative diseases (Nader et al., 2010). The oxidative
stress develops when the levels of antioxidants are lowered
(Tapiero et al., 2004). We have considered whether the
effectiveness of C. islandica in response to T1D is associated
with the induction of antioxidant activity. Our findings
revealed that there were statistically significant differences in
MDA level between the T1D group and T1DþC. islandica
group. In the current study, it was also demonstrated that lichen
extract administration in T1D group significantly decreased the
level of MDA without depending on the dose. From previous
reports, C. islandica extract determined adaptogenic-antistress
effects, confirmed by its actions on oxidative stress parameters
as MDA in laboratory animals (Cernescu et al., 2011b). Recent
studies suggested a strong antioxidant effect of lichen extract
that could ameliorate oxidative stress (Kosanic & Rankovic,
2011). The effects of antioxidants are pronounced in erythro-
cytes because these cells have increased amounts of hemoglo-
bin and iron ions and consequently they are under higher
oxidative stress (Vitturi et al., 2013). The results obtained
in vitro suggest that the membrane fragility increases under
oxidative stress conditions for the patient RBCs and the
protection effect of antioxidants is due to their antioxidant
properties (Moreira et al., 2011).
The protective effect of C. islandica can be explained by
both the direct scavenging of free radicals produced by the
indirect effect and the activation of oxidative repair enzymes.
Gülçin et al. (2002) have reported that C. islandica has strong
superoxide radical scavenging activity on peroxidation of
linoleic acid. Thus, authors have underlined the occurrence of
alterations in antioxidants upon the administration of C.
islandica. It is known that the phenolic compounds of lichen
may contribute directly to antioxidative action (Duh et al.,
1999). And these compounds have inhibitory effects on
mutagenesis and carcinogenesis in humans, when up to 1.0 g
daily ingested from a diet rich in fruits and vegetables
(Tanaka et al., 1988). In the present study, C. islandica had a
pronounced effect on the T1D. In our study, some important
key enzymes, such as erythrocyte SOD, CAT and GSH-Px can
be involved in the inhibitory effect of ROS generation, which
shall be further investigated. In previous studies erythrocyte
SOD and GSH-Px activities were measured. The administra-
tion of C. islandica concluded to increase activities of these
enzymes and thereby to result in the alleviation of oxidative
stress (Kotan et al., 2011).
As known, antioxidant capacity comes from non-enzymes
like glutathione (GSH), as well as enzymes such as SOD,
CAT and GSH-Px (Murri et al., 2010). T1D included vascular
abnormalities, associated with the reduction of SOD, CAT
and GSH-Px activities (Yang et al., 2013). SOD is the primary
step of the defense mechanism in the antioxidant system
against oxidative stress. It catalyzes the dismutation of
superoxide radicals (O2 ) into molecular oxygen (O2) and
H2O2 (Kakarla et al., 2005). CAT activity is decreased in
erythrocytes during T1D and its activity is inhibited by the
superoxide radical (Shailey & Basir, 2012). The suppression
of these enzyme activities has been linked to induction of
oxidative stress (Stoppa et al., 2006). In addition, the observed
decreases in GSH-related enzyme activities indicate that
diabetes may induce oxidative stress in human blood by
altering GSH metabolism (Yavari & Azizova, 2012). GSH-Px
can protect DNA and lipids of the cell against the
peroxidation products (Han, 2011; Kostic et al., 2007). The
observed decline in the activity of GSH-Px in the blood of
DM patients may be ascribed to the reduction in the level of
the GSH and an increase in the level of peroxides (Al-Shebly
& Mansour, 2012). GSH is one of the most abundant
intracellular antioxidants in animal cells. Since it is con-
sidered to be one of the most abundant tripeptides in human
organism and its action against oxidative radicals is well
known. Thus, the balance of GSH-Px enzyme system may
also be essential to remove superoxide anion and peroxides
generated in erythrocytes (Allen & Bradley, 2011).
The enzyme inactivations induced by T1D also corroborate
by the genotoxic findings. The results obtained by us indicate a
significant increase in the ratios of the SCEs in lymphocytes,
which is in accordance with the previous reports (Cinkilic et al.,
2009; Sheth et al., 2006). The SCEs are formed by toxic oxygen
metabolites in cultured human leukocytes and other mamma-
lian cells (Madrigal-Santillán et al., 2010). T1D is related to
LPO and oxidation of DNA in vivo and in vitro (Chistiakov
et al., 2012). So this disease could contribute to the formation
of the genome leading to carcinogenesis (Dobrila-Dintinjana
et al., 2012). Lipid peroxides enter the nucleus where they react
with Feþ2 to generate the alkoxyl radical which attacks DNA
(Fraga & Tappel, 1988). Also, intracellular calcium levels
increase as a result of oxidative damage to cell membranes,
calcium then enters the nucleus where it can activate nucleases
which cause DNA strand breaks (McConkey et al., 1989). DNA
damage and defective DNA repair cause SCEs (Dumitrache
et al., 2011). In this study, the abnormal signs of T1D on blood
cells were dramatically and dose-dependently unchanged by
C. islandica. Hence the rates of SCEs were not unfortunately
fully decreased in lymphocyte cells.
MNs are the results of acentric fragments or lagging
chromosomes that fail to incorporate into either of the daughter
nuclei during telophase of the mitotic cells (Albertini et al.,
2000). In the present study, there were no differences in MN
frequencies in the lymphocytes of T1D patients when
compared with controls. Our current data confirm and
expand previous findings by showing that patients with T1D
have unchanged levels of MNs (Cinkilic et al., 2009).
Notably, previous studies of oxidative damage in DM
patients have used tests, including the comet assay, to
investigate DNA damage (Ross, 2011; Sardas et al., 2001).
Diabetic patients have increased DNA damage as identified by
the comet assay, and this damage may cause an increase in the
risk of cancer (Bonassi et al., 2007). Our results showed a
significant increase in the ratios of the primary DNA damage in
lymphocytes in accordance with the previous reports.
Investigators reported oxidative DNA damage in the comet
assay in both type-1 and type-2 diabetic patients (Palazzo et al.,
2012; Sardas et al., 2001). Moreover, these authors reported
that DNA damage as observed in the comet assay was high in
individuals with T1D. The comet assay has been proposed to be
the most sensitive procedure for detecting DNA fragmentation.
Due to its simplicity and sensitivity, the comet assay has rapidly
gained acceptance as a genotoxicity assay. Additionally, the
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comet assay has shown that strand breaks arise from DNA
damage generated by oxidative stress. Furthermore, the comet
assay has been found to be technically suitable for the routine
measurement of DNA damage (Moller et al., 2000). Our study
revealed that C. islandica extract significantly decreased the
ratios of the primary DNA damage when the values were
comparable with that of the T1D groups.
Growing evidence suggest that one of causes of increased
level of oxidative DNA damage in diabetic patients is reduced
antioxidant defense system (Piwowar et al., 2007). The
biologically fundamental macromolecules such as nucleic
acids and proteins in mammalian cells defend themselves with
antioxidants (Kedziora-Kornatowska et al., 2004). At this
point, our results showed that lichen extract exhibited
antigenotoxic properties at concentrations ranged at 5 and
10 mg mL1 concentrations. C. islandica, as mentioned above,
supported the antioxidant defense mechanism against T1D.
The results obtained in the present study elucidated that DM
also induced a reduction in PI in human lymphocytes. These
data were similar to the findings from earlier studies (Varga
et al., 2011). PI has been used for the assessment of the
cytostatic action of various therapeutic agents (Baka et al.,
2009). C. islandica was useful and increased the PI, which was
decreased by diabetes.
Conclusion
The biochemical and genotoxic tests dealing with C. islandica
are used frequently in the food industry reveal safe results for
a food supplement. The present study is the first report
describing C. islandica’s ability to protect nuclear DNA from
oxidative damage against T1D and it is speculated that
protective effects of lichen extract are a consequence of its
ability to reduce MDA formation and increase associated
antioxidants. In conclusion, we suggest that it may be a
chemopharmaceutical molecule of interest against T1D.
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Kostić N, Caparević Z, Ilić S. (2007). Antioxidant status in type II
diabetes mellitus patients with or without microvascular complica-
tions. Srp Arh Celok Lek 135:143–6.
Kotan E, Alpsoy L, Anar M, et al. (2011). Protective role of methanol
extract of Cetraria islandica (L.) against oxidative stress and
genotoxic effects of AFB1 in human lymphocytes in vitro. Toxicol
Ind Health 27:599–605.
Lao-ong T, Chatuphonprasert W, Nemoto N, Jarukamjorn K. (2012).
Alteration of hepatic glutathione peroxidase and superoxide dismutase
expression in streptozotocin-induced diabetic mice by berberine.
Pharm Biol 50:1007–12.
Madrigal-Santillán E, Morales-González JA, Vargas-Mendoza N, et al.
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Simões-Ambrosio L, Gregório L, Sousa J, et al. (2010). The role of
seasonality on the inhibitory effect of Brazilian green propolis on the
oxidative metabolism of neutrophils. Fitoterapia 81:1102–8.
Singh NP, McCoy MT, Tice RR, Schneider EL. (1988). A simple
technique for quantitation of low levels of DNA damage in individual
cells. Exp Cell Res 175:184–91.
Stoppa GR, Cesquini M, Roman EA, et al. (2006). Aminoguanidine
prevented impairment of blood antioxidant system in insulin-
dependent diabetic rats. Life Sci 78:1352–61.
Tan ALY, Forbes JM, Cooper ME. (2007). AGE, RAGE, and ROS in
diabetic nephropathy. Semin Nephrol 27:130–43.
Tanaka M, Kuei CW, Nagashima Y, Taguchi T. (1988). Application of
antioxidative maillard reaction products from histidine and glucose to
sardine products. Bull Japan Soc Sci Fish 54:1409–14.
Tapiero H, Townsend D, Tew K. (2004). The role of carotenoids in the
prevention of human pathologies. Biomed Pharmacother 58:100–10.
Valente MJ, Baltazar AF, Henrique R, et al. (2011). Biological activities
of Portuguese propolis, protection against free radical-induced
erythrocyte damage and inhibition of human renal cancer cell
growth in vitro. Food Chem Toxicol 49:86–92.
Varga T, Somogyi A, Barna G, et al. (2011). Higher serum DPP-4
enzyme activity and decreased lymphocyte CD26 expression in type 1
diabetes. Pathol Oncol Res 17:925–30.
Vartia K. (1973). Antibiotics in lichens. In: Ahmadjian V, Hale ME, eds.
The Lichens. New York: Academic Press, Inc., 547–61.
Vitturi DA, Sun CW, Harper VM, et al. (2013). Antioxidant functions for
the hemoglobin b93 cysteine residue in erythrocytes and in the
vascular compartment in vivo. Free Radic Biol Med 55:119–29.
Widmer I, Dal Grande F, Excoffier L, et al. (2012). European
phylogeography of the epiphytic lichen fungus Lobaria pulmonaria
and its green algal symbiont. Mol Ecol 21:5827–44.
Yagi K. (1984). Assay for blood plasma or serum. Methods Enzymol 105:
328–31.
Yang H, Fan S, Song D, et al. (2013). Long-term streptozotocin-induced
diabetes in rats leads to severe damage of brain blood vessels and
neurons via enhanced oxidative stress. Mol Med Rep 7:431–40.
Yavari A, Azizova G. (2012). Effect of oxidative stress on immuno-
logical parameters in type 2 diabetes mellitus in the Azerbaijan
Republic. Diabet Met Syndrome, Clin Res Rev 6:195–8.
Yousefi M, Rahimi H, Barikbin B, et al. (2011). Uric acid, a new anti-
oxidant in patients with pemphigus vulgaris. Ind J Dermatol 56:278–81.
Zambare VP, Christopher LP. (2012). Biopharmaceutical potential of
lichens. Pharm Biol 50:778–98.
DOI: 10.3109/13880209.2013.801994 C. islandica against diabetes 1537
